Antifungal resistance

MD: living with CPA, aspergilloma and antifungal resistance

MD shares her experience of…

Patient and clinician discussing aspergillosis research, with illustrated lungs and fungal spores

This Week in Aspergillosis Research: Monitoring CPA, Switching ABPA Biologics and Understanding Antifungal Immunity

Respiratory specialist and patient reviewing a chest CT scan during a follow-up appointment for chronic pulmonary aspergillosis.

Stopping Antifungal Treatment for CPA: Relapse, Monitoring and What Happens Next

Patient and clinician discussing aspergillosis research, with illustrated lungs and fungal spores

This Week in Aspergillosis Research: Dupilumab and ABPA

Clinician reviewing lung research data in an illustration about new findings in aspergillosis care.

Research update: new ABPA treatment results, and lessons from viral infections

Medical illustration of lungs and Aspergillus highlighting new research into the relationship between COPD and aspergillosis.

Weekly Aspergillosis Research Update – 24 August 2026

Illustration showing monoclonal antibodies binding Aspergillus fumigatus and helping macrophages recognise and engulf the fungus.

Beyond antifungal drugs: could antibodies help the immune system fight Aspergillus?

Scientific illustration showing amphotericin B disrupting an Aspergillus fungal cell membrane during research into antifungal resistance.

Amphotericin B resistance in Aspergillus: protecting an important treatment for the future

Aspergillosis Research Update: Corticosteroid Risks, Azole Resistance and Immune Recovery